Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 307

1.

Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.

Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM.

Arch Pediatr Adolesc Med. 2005 Feb;159(2):139-44.

PMID:
15699307
2.

The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women.

Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM.

Contraception. 2004 Feb;69(2):99-104.

PMID:
14759613
3.

Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.

Clark MK, Sowers MR, Nichols S, Levy B.

Fertil Steril. 2004 Dec;82(6):1580-6.

PMID:
15589863
4.

Injectable hormone contraception and bone density: results from a prospective study.

Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM.

Epidemiology. 2002 Sep;13(5):581-7. Erratum in: Epidemiology. 2002 Nov;13(6):749..

PMID:
12192229
5.

Bone mineral density in women using depot medroxyprogesterone acetate for contraception.

Scholes D, Lacroix AZ, Ott SM, Ichikawa LE, Barlow WE.

Obstet Gynecol. 1999 Feb;93(2):233-8.

PMID:
9932562
6.

Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density.

Johnson CC, Burkman RT, Gold MA, Brown RT, Harel Z, Bruner A, Stager M, Bachrach LK, Hertweck SP, Nelson AL, Nelson DA, Coupey SM, McLeod A, Bone HG.

Contraception. 2008 Apr;77(4):239-48. doi: 10.1016/j.contraception.2007.11.002. Epub 2008 Jan 30.

PMID:
18342646
7.

The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.

Orr-Walker BJ, Evans MC, Ames RW, Clearwater JM, Cundy T, Reid IR.

Clin Endocrinol (Oxf). 1998 Nov;49(5):615-8.

PMID:
10197077
8.

Bone density in women receiving depot medroxyprogesterone acetate for contraception.

Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR.

BMJ. 1991 Jul 6;303(6793):13-6. Erratum in: BMJ 1991 Jul 27;303(6796):220.

9.

Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception.

Wanichsetakul P, Kamudhamas A, Watanaruangkovit P, Siripakarn Y, Visutakul P.

Contraception. 2002 Jun;65(6):407-10.

PMID:
12127638
10.

Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.

Paiva LC, Pinto-Neto AM, Faundes A.

Contraception. 1998 Dec;58(6):351-5.

PMID:
10095971
11.

Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.

Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K.

Contraception. 1997 Jul;56(1):1-3.

PMID:
9306024
12.

Long-term depot-medroxyprogesterone acetate and bone mineral density.

Tang OS, Tang G, Yip P, Li B, Fan S.

Contraception. 1999 Jan;59(1):25-9.

PMID:
10342083
13.

Bone density in long term users of depot medroxyprogesterone acetate.

Gbolade B, Ellis S, Murby B, Randall S, Kirkman R.

Br J Obstet Gynaecol. 1998 Jul;105(7):790-4.

PMID:
9692421
14.

Effects of hormonal contraception on bone mineral density after 24 months of use.

Berenson AB, Breitkopf CR, Grady JJ, Rickert VI, Thomas A.

Obstet Gynecol. 2004 May;103(5 Pt 1):899-906.

PMID:
15121563
15.

A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.

Viola AS, Castro S, Bahamondes MV, Fernandes A, Viola CF, Bahamondes L.

Contraception. 2011 Nov;84(5):e31-7. doi: 10.1016/j.contraception.2011.06.012. Epub 2011 Aug 10.

PMID:
22018135
16.

Forearm bone density in users of Depo-Provera as a contraceptive method.

Bahamondes L, Perrotti M, Castro S, Fa├║ndes D, Petta C, Bedone A.

Fertil Steril. 1999 May;71(5):849-52.

PMID:
10231044
17.

Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.

Kaunitz AM, Miller PD, Rice VM, Ross D, McClung MR.

Contraception. 2006 Aug;74(2):90-9. Epub 2006 May 19.

PMID:
16860045
18.

Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling.

Shaarawy M, El-Mallah SY, Seoudi S, Hassan M, Mohsen IA.

Contraception. 2006 Oct;74(4):297-302. Epub 2006 Jun 16.

PMID:
16982229
19.

Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls.

Cromer BA, Stager M, Bonny A, Lazebnik R, Rome E, Ziegler J, Debanne SM.

J Adolesc Health. 2004 Dec;35(6):434-41.

PMID:
15581522
20.

Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections.

Harel Z, Johnson CC, Gold MA, Cromer B, Peterson E, Burkman R, Stager M, Brown R, Bruner A, Coupey S, Hertweck P, Bone H, Wolter K, Nelson A, Marshall S, Bachrach LK.

Contraception. 2010 Apr;81(4):281-91. doi: 10.1016/j.contraception.2009.11.003. Epub 2009 Dec 14.

PMID:
20227543
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk